PE20030970A1 - Formulacion de aerosol para inhalacion que contiene una sal de tiotropio - Google Patents
Formulacion de aerosol para inhalacion que contiene una sal de tiotropioInfo
- Publication number
- PE20030970A1 PE20030970A1 PE2003000359A PE2003000359A PE20030970A1 PE 20030970 A1 PE20030970 A1 PE 20030970A1 PE 2003000359 A PE2003000359 A PE 2003000359A PE 2003000359 A PE2003000359 A PE 2003000359A PE 20030970 A1 PE20030970 A1 PE 20030970A1
- Authority
- PE
- Peru
- Prior art keywords
- formulation
- thiootrope
- tiotrope
- salt
- active substance
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 5
- 150000003839 salts Chemical class 0.000 title abstract 3
- 239000000443 aerosol Substances 0.000 title 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- GVLGAFRNYJVHBC-UHFFFAOYSA-N hydrate;hydrobromide Chemical compound O.Br GVLGAFRNYJVHBC-UHFFFAOYSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 229940037001 sodium edetate Drugs 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 239000003381 stabilizer Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5386—1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Nozzles (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
QUE COMPRENDE: a)UNA O MAS SALES DE TIOTROPIO COMO SUSTANCIA ACTIVA, SIENDO ESTA BROMURO DE TIOOTROPIO O MONOHIDRATO DE BROMURO DE TIOTROPIO, EN UNA CONCENTRACION ENTRE 0,01g/100 ml Y 0,06g/100 ml DE FORMULACION, ESTANDO PRESENTES LA O LAS SALES DE TIOTROPIO DISUELTAS POR COMPLETO EN LA PREPARACION MEDICAMENTOSA; b)AGUA COMO UNICO DISOLVENTE; c)ACIDO PARA AJUSTAR UN VALOR DE pH ENTRE 2,7 Y 3,1, TAL COMO ACIDO CLORHIDRICO; d)UN AGENTE CONSERVANTE FARMACOLOGICAMENTE TOLERABLE COMO CLORURO DE BENZALCONIO; e)UN FORMADOR DE COMPLEJOS Y/O ESTABILIZADOR FARMACOLOGICAMENTE ACEPTABLE, COMO EDETATO SODICO EN UNA CANTIDAD ENTRE 5 mg/100 ml Y 20 mg/100 ml. SE REFIERE TAMBIEN A UN PROCEDIMIENTO PARA PREPARAR LA FORMULACION DESCRITA. DICHA FORMULACION ES APROPIADA PARA NEBULIZAR LA SUSTANCIA ACTIVA POR MEDIO DE UN PULVERIZADOR A FIN DE ADMINISTRAR DICHA SUSTANCIA MEDIANTE INHALACION PARA TRATAMIENTO DEL ASMA Y ENFERMEDADES PULMONARES OBSTRUCTIVAS CRONICAS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10216036A DE10216036A1 (de) | 2002-04-11 | 2002-04-11 | Aerosolformulierung für die Inhalation enthaltend ein Tiotropiumsalz |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20030970A1 true PE20030970A1 (es) | 2004-01-13 |
Family
ID=28458728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2003000359A PE20030970A1 (es) | 2002-04-11 | 2003-04-09 | Formulacion de aerosol para inhalacion que contiene una sal de tiotropio |
Country Status (32)
| Country | Link |
|---|---|
| EP (2) | EP1949892A1 (es) |
| JP (1) | JP2005531528A (es) |
| KR (1) | KR100997219B1 (es) |
| CN (1) | CN1309378C (es) |
| AR (1) | AR039286A1 (es) |
| AT (1) | ATE389391T1 (es) |
| AU (1) | AU2003222791B2 (es) |
| BR (1) | BR0309080A (es) |
| CA (1) | CA2473815C (es) |
| CO (1) | CO5611150A2 (es) |
| CY (1) | CY1108133T1 (es) |
| DE (2) | DE10216036A1 (es) |
| DK (1) | DK1496876T3 (es) |
| EA (1) | EA007228B1 (es) |
| EC (1) | ECSP045358A (es) |
| ES (1) | ES2303897T3 (es) |
| HR (1) | HRP20040932B1 (es) |
| ME (1) | ME00359B (es) |
| MX (1) | MXPA04009818A (es) |
| MY (1) | MY137249A (es) |
| NO (1) | NO334915B1 (es) |
| PE (1) | PE20030970A1 (es) |
| PL (1) | PL371204A1 (es) |
| PT (1) | PT1496876E (es) |
| RS (1) | RS50923B (es) |
| SA (1) | SA03240192B1 (es) |
| SI (1) | SI1496876T1 (es) |
| TW (1) | TWI344851B (es) |
| UA (1) | UA78994C2 (es) |
| UY (1) | UY27754A1 (es) |
| WO (1) | WO2003084519A2 (es) |
| ZA (1) | ZA200405721B (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS20060292A (sr) | 2003-11-03 | 2008-08-07 | Boehringer Ingelheim International Gmbh., | Postupak za dobijanje novih soli tiotropijuma, nove soli tiotropijuma kao takve, kao i farmaceutske formulacije koje ih sadrže |
| CA2617717C (en) * | 2005-08-06 | 2014-02-11 | Boehringer Ingelheim International Gmbh | Use of tiotropium salts in the treatment of severe persistant asthma |
| US20070088030A1 (en) | 2005-10-10 | 2007-04-19 | Barbara Niklaus-Humke | Aerosol formulations for the inhalation of beta-agonists |
| EP1905440A1 (de) * | 2006-09-06 | 2008-04-02 | Boehringer Ingelheim Pharma GmbH & Co. KG | Verwendung einer pharmazeutischen Zusammensetzung enthaltend ein Anticholinergikum zur Abtötung von Mikroorganismen und zur Behandlung von Atemwegsinfektionen |
| EP2044967A1 (de) * | 2007-10-01 | 2009-04-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Zerstäuber |
| JP6335798B2 (ja) | 2012-02-28 | 2018-05-30 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規噴射剤含有チオトロピウム製剤 |
| RU2493827C1 (ru) * | 2012-10-03 | 2013-09-27 | Шолекс Девелопмент Гмбх | Стабильный комбинированный раствор фенотерола гидробромида и ипратропия бромида |
| WO2015065219A1 (ru) * | 2013-10-28 | 2015-05-07 | Шолекс Девелопмент Гмбх | Раствор ипратропия бромида |
| WO2015065223A1 (ru) * | 2013-10-28 | 2015-05-07 | Шолекс Девелопмент Гмбх | Стабильный раствор фенотерола гидробромида |
| GB201507686D0 (en) * | 2015-05-05 | 2015-06-17 | Norton Healthcare Ltd | A stable tiotropium nebuliser solution |
| AU2017363041A1 (en) * | 2016-11-16 | 2019-04-11 | Glenmark Specialty S.A. | Nebulized tiotropium |
| CN115209872B (zh) * | 2020-03-19 | 2024-08-02 | 广州谷森制药有限公司 | 含有酒石酸左旋沙丁胺醇的可吸入制剂 |
| CN114259481A (zh) * | 2021-11-26 | 2022-04-01 | 南京华盖制药有限公司 | 一种奥达特罗复方吸入溶液 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3931041C2 (de) | 1989-09-16 | 2000-04-06 | Boehringer Ingelheim Kg | Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
| SG45171A1 (en) | 1990-03-21 | 1998-01-16 | Boehringer Ingelheim Int | Atomising devices and methods |
| IL107120A (en) | 1992-09-29 | 1997-09-30 | Boehringer Ingelheim Int | Atomising nozzle and filter and spray generating device |
| DE19536902A1 (de) | 1995-10-04 | 1997-04-10 | Boehringer Ingelheim Int | Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung |
| DE19536903C2 (de) | 1995-10-04 | 1998-09-10 | Boehringer Ingelheim Int | Vorrichtung zum Haltern eines fluidischen Bauteils |
| DE19545226C1 (de) | 1995-12-05 | 1997-06-19 | Boehringer Ingelheim Int | Sperrspannwerk für einen federbetätigten Abtrieb |
| DE19653969A1 (de) * | 1996-12-20 | 1998-06-25 | Boehringer Ingelheim Kg | Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole |
| DE19742439C1 (de) | 1997-09-26 | 1998-10-22 | Boehringer Ingelheim Int | Mikrostrukturiertes Filter |
| DE19847968A1 (de) * | 1998-10-17 | 2000-04-20 | Boehringer Ingelheim Pharma | Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen |
| WO2002036104A2 (de) * | 2000-10-31 | 2002-05-10 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalative lösungsformulierung mit einem tiotropiumsalz |
-
2002
- 2002-04-11 DE DE10216036A patent/DE10216036A1/de not_active Withdrawn
-
2003
- 2003-02-04 UA UA20041109194A patent/UA78994C2/uk unknown
- 2003-04-02 EP EP08152138A patent/EP1949892A1/de not_active Withdrawn
- 2003-04-02 ME MEP-2008-543A patent/ME00359B/me unknown
- 2003-04-02 PL PL03371204A patent/PL371204A1/xx not_active Application Discontinuation
- 2003-04-02 SI SI200331206T patent/SI1496876T1/sl unknown
- 2003-04-02 BR BR0309080-9A patent/BR0309080A/pt not_active Application Discontinuation
- 2003-04-02 WO PCT/EP2003/003438 patent/WO2003084519A2/de not_active Ceased
- 2003-04-02 KR KR1020047016052A patent/KR100997219B1/ko not_active Expired - Lifetime
- 2003-04-02 EA EA200401305A patent/EA007228B1/ru not_active IP Right Cessation
- 2003-04-02 ES ES03718724T patent/ES2303897T3/es not_active Expired - Lifetime
- 2003-04-02 CA CA2473815A patent/CA2473815C/en not_active Expired - Fee Related
- 2003-04-02 DE DE50309414T patent/DE50309414D1/de not_active Expired - Lifetime
- 2003-04-02 AU AU2003222791A patent/AU2003222791B2/en not_active Expired
- 2003-04-02 EP EP03718724A patent/EP1496876B1/de not_active Expired - Lifetime
- 2003-04-02 MX MXPA04009818A patent/MXPA04009818A/es active IP Right Grant
- 2003-04-02 RS YUP-879/04A patent/RS50923B/sr unknown
- 2003-04-02 CN CNB038082330A patent/CN1309378C/zh not_active Ceased
- 2003-04-02 PT PT03718724T patent/PT1496876E/pt unknown
- 2003-04-02 DK DK03718724T patent/DK1496876T3/da active
- 2003-04-02 HR HRP20040932AA patent/HRP20040932B1/hr not_active IP Right Cessation
- 2003-04-02 AT AT03718724T patent/ATE389391T1/de active
- 2003-04-02 JP JP2003581759A patent/JP2005531528A/ja active Pending
- 2003-04-09 PE PE2003000359A patent/PE20030970A1/es not_active Application Discontinuation
- 2003-04-09 MY MYPI20031314A patent/MY137249A/en unknown
- 2003-04-09 UY UY27754A patent/UY27754A1/es not_active Application Discontinuation
- 2003-04-10 TW TW092108240A patent/TWI344851B/zh not_active IP Right Cessation
- 2003-04-11 AR ARP030101267A patent/AR039286A1/es not_active Application Discontinuation
- 2003-07-07 SA SA03240192A patent/SA03240192B1/ar unknown
-
2004
- 2004-07-19 ZA ZA200405721A patent/ZA200405721B/en unknown
- 2004-09-23 NO NO20044001A patent/NO334915B1/no not_active IP Right Cessation
- 2004-10-08 CO CO04100971A patent/CO5611150A2/es active IP Right Grant
- 2004-10-11 EC EC2004005358A patent/ECSP045358A/es unknown
-
2008
- 2008-06-11 CY CY20081100623T patent/CY1108133T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100211479B1 (ko) | 3-[2-(디메틸아미노)에틸]-n-메틸-1h-인돌-5-메탄술폰아미드의 비강 투여 제제 | |
| PE20030970A1 (es) | Formulacion de aerosol para inhalacion que contiene una sal de tiotropio | |
| ES2425221T3 (es) | Nuevos métodos y composiciones para suministro por vía transmucosa potenciado de péptidos y proteínas | |
| ES2626134T3 (es) | Composiciones de bepotastina | |
| JP4827725B2 (ja) | 医薬品組成物 | |
| JP2019031514A5 (es) | ||
| RU2005100781A (ru) | Комбинация азеластина и стероидов | |
| PE20120023A1 (es) | Formulacion farmaceutica para aerosoles con dos o mas principios activos y al menos una sustancia tensioactiva | |
| JP2012533554A (ja) | 小児のためのオロパタジン経鼻噴霧剤レジメン | |
| ES2935684T3 (es) | Formulaciones de epinefrina intranasales y métodos para el tratamiento de enfermedades | |
| JP2009521473A5 (es) | ||
| JP2015528501A5 (es) | ||
| ES2234681T3 (es) | Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa. | |
| HUP0303877A2 (hu) | Imidazotriazinon-tartalmú készítmények nazális alkalmazásra | |
| JP2005531528A5 (es) | ||
| JP2007501817A5 (es) | ||
| JP5149308B2 (ja) | 局所的鼻腔投与のためのオロパタジンの製剤 | |
| CN103841958A (zh) | 组合物 | |
| PE20030092A1 (es) | Formulacion de una solucion de inhalacion con una sal de tiotropio | |
| ES2332462T3 (es) | Composicion farmaceutica de derivados de piperazina. | |
| CN1863529A (zh) | 用于治疗皮肤病症的包括替美斯丁的局部组合物 | |
| KR20160138179A (ko) | 수성 의약 조성물 | |
| ES2279435T3 (es) | Composicion farmaceutica de piribedil para su administracion nasal. | |
| HK40092206A (zh) | 鼻内肾上腺素制剂及治疗疾病的方法 | |
| ES2612544T3 (es) | Nuevo uso para a-simpaticomiméticos con estructura de 2-imidazolina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |